| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Atlas Copco AB: Nomination Committee proposes Martin Lundstedt as new Board member of Atlas Copco AB | 360 | GlobeNewswire (Europe) | Nacka, February 20, 2026: Atlas Copco AB's Nomination Committee today announced its proposal for the Board of Directors ahead of the Annual General Meeting 2026. The Committee proposes Martin Lundstedt... ► Artikel lesen | |
| Fr | EQS-News: Acceleronix und IDEMIA Secure Transactions starten IFPP Early Access Programm auf dem MWC26 Barcelona gemeinsam mit Tele2 IoT | 321 | EQS Group (DE) | EQS-News: Acceleronix
/ Schlagwort(e): Produkteinführung/Sonstiges
Acceleronix und IDEMIA Secure Transactions starten IFPP Early Access Programm auf dem MWC26 Barcelona gemeinsam... ► Artikel lesen | |
| Fr | FDA Approves AstraZeneca's Calquence Plus Venetoclax For Chronic Lymphocytic Leukemia | 302 | AFX News | LONDON (dpa-AFX) - AstraZeneca PLC (AZN) on Friday said the US Food and Drug Administration (FDA) has approved its Calquence in combination with venetoclax for the treatment of adults with chronic... ► Artikel lesen | |
| Fr | Acceleronix and IDEMIA Secure Transactions launch IFPP Early Access Program at MWC26 Barcelona with Tele2 IoT | 218 | PR Newswire | BARCELONA, Spain, Feb. 20, 2026 /PRNewswire/ -- Acceleronix, a global leader in IoT solutions and services, and IDEMIA Secure Transactions, a global leader in payment and connectivity solutions... ► Artikel lesen | |
| Fr | Atlas Copco AB: US vacuum and leak testing company to become part of Atlas Copco Group | 98 | GlobeNewswire (Europe) | Nacka, Sweden, February 20, 2026: LACO Technologies, Inc. ("LACO") a company designing and manufacturing vacuum solutions and leak testing systems, will become part of Atlas Copco Group.
LACO is based... ► Artikel lesen | |
| Fr | AstraZeneca PLC: Fixed-duration Calquence combo approved in US | 94 | GlobeNewswire (Europe) | 20 February 2026
Calquence plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukaemia in the 1st-line setting
Calquence plus venetoclax... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| SVENSKA HANDELSBANKEN AB A | 13,565 | 1,41 | +10,39 % | 8,00 | 26.03.2026 | |
| SWEDBANK | 32,830 | 2,03 | +6,18 % | 20,45 | 25.03.2026 | |
| SEB AB A | 18,375 | 1,08 | +5,88 % | 8,50 | 25.03.2026 | |
| NORDEA BANK | 16,745 | 0,94 | +5,61 % | 0,96 | 25.03.2026 | |
| VOLVO | 33,020 | 1,73 | +5,24 % | 8,50 | 09.04.2026 | |
| TELIA | 4,215 | 0,19 | +4,51 % | 0,51 | 28.10.2026 | |
| H&M | 17,080 | 0,64 | +3,75 % | 3,55 | 06.05.2026 | |
| ESSITY AB B | 26,510 | 0,77 | +2,90 % | 8,75 | 27.03.2026 | |
| SKANSKA | 25,930 | 0,75 | +2,89 % | 8,50 | 01.04.2026 | |
| ERICSSON | 9,612 | 0,27 | +2,81 % | 1,50 | 01.04.2026 |
| Aktien WKN | Akt. Kurs Vortag | +/- % | Zeit | ||
|---|---|---|---|---|---|
| ABB LTD 919730 Tradegate | 77,160 76,74 | +0,08 +0,10 % | 20.02. | ||
| ADDTECH AB A2QEPD Tradegate | 30,420 30,520 | -0,200 -0,65 % | 20.02. | ||
| ALFA LAVAL AB 577335 Tradegate | 49,530 48,950 | +0,230 +0,47 % | 20.02. | ||
| ASSA ABLOY AB A14TVM Tradegate | 35,920 35,480 | +0,010 +0,03 % | 20.02. | ||
| ASTRAZENECA PLC 886455 Tradegate | 174,450 176,55 | +0,85 +0,49 % | 20.02. | ||
| ATLAS COPCO AB A A3DLE9 Frankfurt | 18,405 18,240 | +0,165 +0,90 %
| 20.02. | ||
| BOLIDEN AB A3D69V Tradegate | 62,700 61,12 | -0,08 -0,13 % | 20.02. | ||
| EPIROC AB A A3CPHU Frankfurt | 24,160 24,120 | +0,040 +0,17 % | 20.02. | ||
| EQT AB A2PQ7G Tradegate | 27,800 27,770 | -0,050 -0,18 % | 20.02. | ||
| ESSITY AB B A2DS20 Tradegate | 26,510 26,510 | -0,300 -1,12 % | 20.02. |